We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca to Cut 3,000 Jobs in the Face of Generic Competition
AstraZeneca to Cut 3,000 Jobs in the Face of Generic Competition
March 5, 2007
Despite a 28 percent increase in profits and an 11 percent rise in sales, AstraZeneca will cut approximately 3,000 jobs to help with anticipated losses from generic competition, the company announced.